136
Among the stocks in the spotlight on Wall Street is the rally in Horizon Therapeutics, which soars 15% in premarket after the company announced it will be acquired by US biotech group Amgen, for $116.50 per share in cash .
Horizon Therapeutics was valued at more than $27.8 billion. Amgen shares lose more than 2% in the pre-market.